{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Activities
  • On-Demand Activities
  • Grand Rounds and RSS
  • CE Planning Process
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
PLEASE CREATE AN ACCOUNT IF:

• You have never attended a Cedars-Sinai CE activity
• OR You are a NEW member of the Cedars-Sinai Medical Staff since August 2023

If you do NOT meet either of the criteria above, please DO NOT CREATE AN ACCOUNT:

• If you do not know which email address is used for your account, please contact the Cedars-Sinai Office of CME.
• Accounts for existing Cedars-Sinai Medical Staff (prior to August 2023) use the primary email on file with the Medical Staff Office.

For ALL USERS: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ATC
  • BSN
  • CCC-SLP
  • CCLS
  • CPhT
  • CRNA
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • LCGC
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

On-Demand Highlights from the 10th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Conference


On-Demand Highlights from the 10th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Conference Banner

  • Overview
  • Register
  • Faculty


Date & Location
Monday, January 3, 2022, 8:00 AM - Thursday, June 30, 2022, 4:30 PM, Other

Target Audience
Specialties - Hematology, Internal Medicine, Oncology, Pain Management, Radiation Oncology, Surgery

Overview
The On-Demand Highlights from the 10th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Conference will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The highlights are from the in-person activity that took place November 12-13, 2021 at the Sofitel Hotel in Los Angeles, CA. This is intended for healthcare professionals that were unable to attend the in-person activity. To view the full list of on-demand highlights, click on Content and Tests.

Objectives
  1. Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of cancer patients
  2. Develop personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options
  3. Integrate appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes
  4. Utilize AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
  5. Anticipate the needs and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team

Registration

Physicians: $75
Non-Physicians: $75
Residents/Fellows:  Free

This is intended for healthcare professionals that were unable to attend the in-person activity. If you were registered for the in-person activity, you have access to this content via the on-line course syllabus.


Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai. 


Accreditation

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Enduring Material for a maximum of 10.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (10.00 hours), Non-Physician AMA Attendance (10.00 hours)


Keywords: ONLINEAMA



Mitigation of Relevant Financial Relationships


Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Faculty Photos
Monica M. Mita, MD
Cedars-Sinai
Course Director
Contracted Research-Boehringer Ingelheim Pharmaceuticals, Inc. Tesaro Alliance Sanofi-Aventis Astex Pharmaceuticals, Inc. Pfizer Inc., U.S. Pharmaceuticals Group BeiGene Hoffman-La Roche Medivir AB Astra Zeneca, L.P. Merus Southwest Oncology Group Seagen (Seattle Genetics, Inc.) Amphivena Therapeutics Hummingbird Bioscience Immix Biopharma, Inc. Spring Bank Pharmaceuticals Changchun Intellicrown Pharmaceutical Co., Ltd Daiichi Sankyo Genzada Pharmaceuticals Incyte Corporation Kronos Bio Linnaeus Therapeutics, Inc. AbbVie Minneamrita Therapeutics, LLC Molecular Template, Inc. Oxford Bio Therapeutics Rgenix, Inc. SQZ Biotechnologies Tizona Therapeutics HiberCell, Inc Jounce Therapeutics Syros Pharmaceuticals, Inc Theratechnologies Inc. NeuPharma, Inc.
Robert A. Figlin, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Faculty Photos
Alain Mita, MD
Cedars-Sinai
Course Director, Faculty
Contracted Research-Astellas Pharma US, Inc. Roche - Genentech Bristol-Myers Squibb Company Five Prime Therapeutics, Inc. Xencor Qurient Co. Ltd. ALX Oncology, Inc. Fusion Pharmaceuticals Gilead Sciences, Inc. Kezar Life Sciences Astex Pharmaceuticals, Inc. BioNTech Pfizer Inc., U.S. Pharmaceuticals Group Southwest Oncology Group IMV Inc Janssen R&D LLC Astra Zeneca, L.P. Molecular Template, Inc. Mundipharma - EDO GmbH
Faculty Photos
Ani Balmanoukian, MD
The Angeles Clinic
Faculty
Speaker-Bristol-Myers Squibb|Speaker-AstraZeneca|Speaker-Genentech, Inc.
Faculty Photos
Reva Basho, MD
Cedars-Sinai
Faculty
Consultant-Genomic Health (Relationship has ended)|Consultant-AstraZeneca (Relationship has ended)|Consultant-Biotheranostics (Relationship has ended)|Consultant-Pfizer, Inc. (Relationship has ended)|Speaker-Genentech, Inc. (Relationship has ended)|Speaker-Seattle Genetics|Other: Honoraria-MJH Healthcare (Relationship has ended)|PrincipalNamedInvestigator-Seattle Genetics|PrincipalNamedInvestigator-Merck and Company, Inc.|PrincipalNamedInvestigator-Eli Lilly and Company|PrincipalNamedInvestigator-Takeda Pharmaceuticals, Inc.
Faculty Photos
Jun Gong, MD
Cedars-Sinai
Faculty
Advisor-EMD Serono (Relationship has ended)|Advisor-Elsevier|Advisor-Exelixis (Relationship has ended)|Advisor-QED Therapeutics (Relationship has ended)|Advisor-Natera (Relationship has ended)|Advisor-Bayer Corporation (Relationship has ended)|Advisor-Basilea (Relationship has ended)|Advisor-HalioDx (Relationship has ended)|Advisor-Eisai, Inc. (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Advisor-Aveo (Relationship has ended)
Aaron Goodman, MD
UC San Diego Health
Faculty
Consultant-Seattle Genetics|Consultant-EUSA Pharma|Advisor-Shoreline (Relationship has ended)
Kenneth Kim, MD, MHPE

Faculty
Razelle Kurzrock, MD
Medical College of Wisconsin
Faculty
Dr. Kurzrock has received research funding from Biological Dynamics, Boehringer Ingelheim, Debiopharm, Foundation Medicine, Genentech, Grifols, Guardant, Incyte, Konica Minolta, Medimmune, Merck Serono, Omniseq, Pfizer, Sequenom, Takeda, and TopAlliance; as well as consultant and/or speaker fees and/or advisory board for Actuate Therapeutics, AstraZeneca, Bicara Therapeutics, Biological Dynamics, EISAI, EOM Pharmaceuticals, Iylon, Merck, NeoGenomics, Neomed, Pfizer, Prosperdtx, Roche, TD2/Volastra, Turning Point Therapeutics, X-Biotech; has an equity interest in CureMatch Inc., CureMetrix, and IDbyDNA; serves on the Board of CureMatch and CureMetrix,and is a co-founder of CureMatch.-Relationship_has_not_ended
John E. Lee, LCGC
Samuel Oschin Comprehensive Cancer Center
Faculty
Nothing to disclose
Joyce O'Shaughnessy, MD
Baylor-Sammons Cancer Center
Faculty
Consultant-Abbvie|Consultant-Amgen|Consultant-Aptitude Health|Consultant-AstraZeneca|Consultant-Bayer Corporation|Consultant-Bristol-Myers Squibb|Consultant-Celgene|Consultant-Daiichi Sankyo|Consultant-Eisai, Inc.|Consultant-Genentech, Inc.|Consultant-G1 Therapeutics|Consultant-Gilead Sciences|Consultant-Immunomedics|Consultant-Ipsen Pharma|Consultant-Eli Lilly and Company|Consultant-Merck and Company, Inc.|Consultant-Myriad|Consultant-Novartis AG|Consultant-Ontada|Consultant-Pfizer, Inc.|Consultant-Pierre Fabre|Consultant-Puma Biotechnology|Consultant-Prime Oncology|Consultant-Roche|Consultant-Samsung Bioepis|Consultant-Sanofi-Aventis|Consultant-Seagen|Consultant-Takeda Pharmaceuticals, Inc.
Faculty Photos
Arsen Osipov, MD
Cedars-Sinai
Faculty
Nothing to disclose
Faculty Photos
Sukhmani Padda, MD
Cedars-Sinai
Faculty
PrincipalNamedInvestigator-Epicentrx (Relationship has ended)|PrincipalNamedInvestigator-Bayer Corporation (Relationship has ended)|PrincipalNamedInvestigator-Boehringer Ingelheim Vetmedica GmbH (Relationship has ended)|Advisor-Janssen Pharmaceuticals|Advisor-Sanofi-Aventis|Advisor-Mirati Therapeutics|Speaker-OncLive (Relationship has ended)|Consultant-Jazz Pharmaceuticals (Relationship has ended)|Consultant-Physician Education Resource (PER) (Relationship has ended)|Advisor-Genentech, Inc. (Relationship has ended)|Independent ContractorResearcher-Nanobiotix (Relationship has ended)|Advisor-AstraZeneca|Advisor-G1 Therapeutics (Relationship has ended)|Advisor-Blueprint (Relationship has ended)|Speaker-California Consortium/MECC Global Meetings (Relationship has ended)
Zachary Zumsteg, MD
Cedars-Sinai
Faculty
Nothing to disclose
Hilary Lachoff, RN
Cedars-Sinai
Planner (old label)
Nothing to disclose


CE Disclosure Form  | CE Application  | Privacy  |  Cedars-Sinai CME Homepage

Contact Us: [email protected]

        

© 2025 Cedars-Sinai. All Rights Reserved. A 501(c)(3) non-profit organization